MARKET WIRE NEWS
  1. Home
  2. Stock
  3. REGN
  4. News
REGN
Quote
Short
News
Articles
Message Board

Regeneron Pharmaceuticals Inc. (NASDAQ : REGN ) News

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) News Releases

REGN News Releases
REGN : NASDAQ
Motley Fool
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
REGN : NASDAQ
SeekingAlpha
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Leerink Global Healthcare Conference 2026 Transcript
REGN : NASDAQ
SeekingAlpha
Regeneron: Fairly Valued Now After A Stellar Upswing
REGN : NASDAQ
GlobeNewswire
Regeneron Science Talent Search 2026 Recognizes America's Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
REGN : NASDAQ
SeekingAlpha
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
REGN : NASDAQ
SeekingAlpha
Nasdaq reverses losses, turns green with help of semis
REGN : NASDAQ
KlickAnalytics
REGN Price Target Alert: $818.00. Issued by Truist Financial
REGN : NASDAQ
SeekingAlpha
Regeneron-licensed obesity drug shows positive phase 3 results in China
REGN : NASDAQ
GlobeNewswire
Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
REGN : NASDAQ
SeekingAlpha
FDA plans to relax testing rules to encourage biosimilar drugs: report

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.